This Human Rights Day, DKMS highlights the urgent need for stem cell transplants for South African children battling rare ...

This Human Rights Day, DKMS highlights the urgent need for stem cell transplants for South African children battling rare ...

Clinigen, the global speciality pharmaceutical services group, today announced that Equity Pharmaceuticals, part of the Clinigen Group, has entered into a new collaboration with Servier, an ...

British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of ...

A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.

India's gene therapy for blood cancers shows 73% response rate, offering hope and cost-effective treatment for patients.

AstraZeneca, headquartered in Cambridge, could pay up to $1 billion on a cash and debt-free basis for Belgian company ...

An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in ...

The study looked at patients with leukaemia, which occurs in bone marrow, and lymphoma, which affects the lymphatic system.